These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27378136)

  • 1. Atypical presentation of autoimmune lymphoproliferative syndrome due to CASP10 mutation.
    Tripodi SI; Mazza C; Moratto D; Ramenghi U; Caorsi R; Gattorno M; Badolato R
    Immunol Lett; 2016 Sep; 177():22-4. PubMed ID: 27378136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
    Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
    Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants in CASP10, a diagnostic challenge: Single center experience and review of the literature.
    Matas Pérez E; Valdivieso Shephard JL; Bravo García-Morato M; Robles Marhuenda Á; Martinez-Ojinaga Nodal E; Prieto Bozano G; González Casado I; Salamanca Fresno L; Méndez Echevarria A; Del Rosal Rabes T; Allende Martínez L; López-Granados E; Rodríguez Pena R
    Clin Immunol; 2021 Sep; 230():108812. PubMed ID: 34329798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
    Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
    Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.
    Nabhani S; Ginzel S; Miskin H; Revel-Vilk S; Harlev D; Fleckenstein B; Hönscheid A; Oommen PT; Kuhlen M; Thiele R; Laws HJ; Borkhardt A; Stepensky P; Fischer U
    Haematologica; 2015 Sep; 100(9):1189-98. PubMed ID: 26113417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
    Zhu S; Hsu AP; Vacek MM; Zheng L; Schäffer AA; Dale JK; Davis J; Fischer RE; Straus SE; Boruchov D; Saulsbury FT; Lenardo MJ; Puck JM
    Hum Genet; 2006 Apr; 119(3):284-94. PubMed ID: 16446975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases.
    Shiota M; Yang X; Kubokawa M; Morishima T; Tanaka K; Mikami M; Yoshida K; Kikuchi M; Izawa K; Nishikomori R; Okuno Y; Wang X; Sakaguchi H; Muramatsu H; Kojima S; Miyano S; Ogawa S; Takagi M; Hata D; Kanegane H
    J Clin Immunol; 2015 Jul; 35(5):454-8. PubMed ID: 25896945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa.
    Tadaki H; Saitsu H; Kanegane H; Miyake N; Imagawa T; Kikuchi M; Hara R; Kaneko U; Kishi T; Miyamae T; Nishimura A; Doi H; Tsurusaki Y; Sakai H; Yokota S; Matsumoto N
    Int J Immunogenet; 2011 Aug; 38(4):287-93. PubMed ID: 21382177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders.
    Oliveira Mendonça L; Matucci-Cerinic C; Terranova P; Casabona F; Bovis F; Caorsi R; Fioredda F; Palmisani E; Grossi A; Guardo D; Bustaffa M; Volpi S; Ceccherini I; Ravelli A; Dufour C; Miano M; Gattorno M
    Rheumatology (Oxford); 2022 Feb; 61(2):696-704. PubMed ID: 33909886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
    Price S; Shaw PA; Seitz A; Joshi G; Davis J; Niemela JE; Perkins K; Hornung RL; Folio L; Rosenberg PS; Puck JM; Hsu AP; Lo B; Pittaluga S; Jaffe ES; Fleisher TA; Rao VK; Lenardo MJ
    Blood; 2014 Mar; 123(13):1989-99. PubMed ID: 24398331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexplained lymphadenopathies: autoimmune lymphoproliferative syndrome in an adult patient.
    Leal-Seabra F; Costa GS; Coelho HP; Oliveira A
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27979843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
    Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
    J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of common variable immunodeficiency patients and healthy individuals using autoimmune lymphoproliferative syndrome biomarkers.
    Roberts CA; Ayers L; Bateman EA; Sadler R; Magerus-Chatinet A; Rieux-Laucat F; Misbah SA; Ferry BL
    Hum Immunol; 2013 Dec; 74(12):1531-5. PubMed ID: 23993982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder.
    Jeffreys SM; Levy RA; Crary SE
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):e305-e308. PubMed ID: 28991130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of autoimmune lymphoproliferactive syndrome and literature review].
    Liu L; Hu J; Ma J; Li X; Li F; Li C
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):923-6. PubMed ID: 25619350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic functions and gene expression profile distinct double-negative cells from single positive cells in the autoimmune lymphoproliferative syndrome.
    Lev A; Simon AJ; Amariglio N; Rechavi G; Somech R
    Autoimmun Rev; 2012 Aug; 11(10):723-30. PubMed ID: 22273982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.